87133-21-9

Basic information

• Product Name: 4-Acetoxy-3,5-di-tert-butylbenzaldehyde
• Synonyms: 4-Acetoxy-3,5-di-tert-butylbenzaldehyde
• CAS NO: 87133-21-9
• Molecular Weight: 276.376
• Mol File: 87133-21-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-Acetoxy-3,5-di-tert-butylbenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Acetoxy-3,5-di-tert-butylbenzaldehyde(87133-21-9)
• EPA Substance Registry System: 4-Acetoxy-3,5-di-tert-butylbenzaldehyde(87133-21-9)

Safety Data

• Hazardous Substances Data: 87133-21-9(Hazardous Substances Data)

Upstream product

• 128-37-0 2,6-di-tert-butyl-4-methyl-phenol 
• 108-24-7 acetic anhydride 
• 64-19-7 acetic acid 
• 65678-11-7 3-(1,1-Dimethylethyl)-4-hydroxy-benzaldehyde 
• 1620-98-0 3,5-di-t-butyl-4-hydroxybenzaldehyde 
• 859793-58-1 α,α,4-triacetoxy-3,5-di-tert-butyltoluene 

Downstream Products

• 273396-82-0 α-(4-acetoxy-3,5-di-tert-butylphenyl)-N-1-hydroxy-2-methylprop-2-ylnitrone 

Relevant articles and documents

Synthesis and molecular shuttling of [2]rotaxanes under mild conditions

[2]Rotaxanes constructed with an ethereal end-capped axle and a dibenzo-24-crown-8 wheel were synthesized from pseudorotaxanes bearing an alcoholic terminus and diaryldiazomethanes using diphenyl phosphate as a catalyst. The reaction proceeded at room temperature in nonpolar solvents within several hours. The [2]rotaxanes thus obtained behaved as ammonium salts derived from a very strong base such as DBU. Thus, the amine form of the [2]rotaxane reacted with a weak acid, CO2H2O, to give a hydrogencarbonate salt of the [2]rotaxane, which turned back to the amine form after drying followed by evacuation.

3,4,5-trisubstituted aryl nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation

Disclosed are 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing such compounds. The 3,4,5-trisubstituted aryl nitrone compounds have the formula: where R1-R4are as defined in the specification. The disclosed compositions are useful as therapeutics for inflammation-related conditions in mammals, such as arthritis, and as analytical reagents for detecting free radicals.